The anti-mycobacterial activity of the cytochrome bcc inhibitor Q203 can be enhanced by small-molecule inhibition of cytochrome bd
Abstract Mycobacterial energy metabolism currently attracts strong attention as new target space for development of anti-tuberculosis drugs. The imidazopyridine Q203 targets the cytochrome bcc complex of the respiratory chain, a key component in energy metabolism. Q203 blocks growth of Mycobacterium...
Saved in:
Main Authors: | Ping Lu, Amer H. Asseri, Martijn Kremer, Janneke Maaskant, Roy Ummels, Holger Lill, Dirk Bald |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/f3ff05a4c9b840efb2333c8bfd9914f6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cardiolipin enhances the enzymatic activity of cytochrome bd and cytochrome bo 3 solubilized in dodecyl-maltoside
by: Amer H. Asseri, et al.
Published: (2021) -
Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
by: Shan Zhou, et al.
Published: (2021) -
Cryo-EM structure of mycobacterial cytochrome bd reveals two oxygen access channels
by: Weiwei Wang, et al.
Published: (2021) -
Structure of Escherichia coli cytochrome bd-II type oxidase with bound aurachin D
by: Antonia Grauel, et al.
Published: (2021) -
Cytochrome bd promotes Escherichia coli biofilm antibiotic tolerance by regulating accumulation of noxious chemicals
by: Connor J. Beebout, et al.
Published: (2021)